Physician profile
Beemen N Khalil
NPI 1427296110
$1,077,776.14
in general payments reported to CMS, 2019-2025
10 companies · $240K in 2025
The $240K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,900 · 2020: $81K · 2021: $187K · 2022: $172K · 2023: $185K · 2024: $207K · 2025: $240K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $519K · Travel and Lodging: $83K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $8,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $518,850.00 |
| Travel and Lodging | $83,365.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,000.00 |
| Food and Beverage | $8,358.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,076,221.83 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $701.25 | 2022-2025 | Signia, Parietene Ds, Dextile |
| Tela Bio, INC. | $255.89 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Nevro Corp. | $219.39 | 2019-2020 | |
| Integra Lifesciences Corporation | $149.12 | 2021 | |
| Teleflex LLC | $116.45 | 2024 | Titan Sgs |
| Davol INC. | $44.42 | 2022-2023 | Bard 3dmax Mesh |
| Ethicon US, LLC | $26.86 | 2023 | Vistaseal |
| W. L. Gore & Associates, INC. | $21.68 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Hologic Sales and Service, LLC | $19.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beemen Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.